Recent Finacing
Recent Raise
Inventiva is a biopharmaceutical company developing nuclear receptor, transcription factor, and epigenetic modulator therapies, advancing lanifibranor (NASH, systemic sclerosis) and odiparcil (MPS), with R&D near Dijon and industry partnerships.
